General Information
Revision date
2020-04-23
Product name
Suxibuzone
CAS No.
27470-51-5
1.2.1 Relevant identified uses
of the substance or or mixture mixture and
1.2.2. Uses advised against
advised against
Icons in SDS
Company Information
company name
BLD Pharmatech
e-mail address of the competent person responsible for the Safety Data Sheet
sales-usa@bldpharm.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
SECTION 2: Hazards identification
OSHA IDENTIFICATION 2.1
2.1 Classification of the substance or mixture
Classification of of the the substance substance or or mixture mixture GHS Classification in in accordance accordance with with 29 29 CFR CFR 1910 1910 (OSHA (OSHA HCS) HCS) Acute toxicity, oral , acute toxicity, dermal and acute toxicity, inhalation (Category 4) H302+H312+H332 No Resource File 2.2 2.2 GHS
2.2 Label elements
elements, including including precautionary
Signal word
Warning
Hazard statements
Hazard statement(s) H302+H312+H332 Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
Precautionary statement(s) P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P312+P330 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth. 2.3 Other
2.3 Other hazards
hazards. Additional precautionary phrases are located throughout the safety data sheet. 3. 3.
